AgenciesMahindra & Mahindra Financial Services, incorporated in the year 1991, is a Large Cap company (having a market cap of Rs 37436.56 Crore) operating in NBFC sector.
Mahindra & Mahindra Financial Services key Products/Revenue Segments include Interest, Fees & Commission Income, Rental Income, Income From Sale Of Share & Securities for the year ending 31-Mar-2023.
Financials
For the quarter ended 30-06-2023, the company has reported a Consolidated Total Income of Rs 3636.91 Crore, up 2.84 % from last quarter Total Income of Rs 3536.35 Crore and up 24.81 % from last year same quarter Total Income of Rs 2913.95 Crore. Company has reported net profit after tax of Rs 348.45 Crore in latest quarter.
Investment Rationale
M&M Fin continued to report a healthy business momentum as it is benefiting from strong sectoral tailwinds and its parent M&M’s strong recovery in auto volumes. The brokerage expects this momentum to be sustained in FY2024. Additionally, the company is diversifying its growth engines and increasing its non-vehicle financing share in SME, LAP, and digital segments. Asset-quality metrics are stable on account of strong collection efficiency.
Promoter/FII Holdings
Promoters held 52.16 per cent stake in the company as of 30-Jun-2023, while FIIs owned 13.92 per cent, DIIs 19.62 per cent.
Friday, 08 Sep, 2023- Front Page
- Pure Politics
- ET Markets
- Smart Investing
- Learn more about our print editionMore
IT Hardware Imports Surge in Aug after Licensing OrderIndia’s IT hardware imports surged as much as 50% in August from July, ahead of licensing rules taking effect on November 1. Companies advanced procurements fearing a supply crunch, said manufacturers and a leading system integrator that buys from distributors and producers and supplies to enterprises.
‘Look to Export AI Products from Nvidia India Arm’Nvidia, the world’s pre-eminent maker of hardware and software for artificial intelligence tools, envisions exporting AI products from its Indian arm, CEO and co-founder of the $27-billion firm, Jensen Huang told researchers at India’s top technology institutes this week, according to the people present at the interaction.
DCGI Collating Data of Pharma PlantsAfter a major drive by the government against spurious and substandard drugs, India’s drug regulator has started collating and compiling the profiles of pharmaceutical plants in the country.The Drug Controller General of India (DCGI) has asked drug companies to provide details of each of their units operational in the country.
Read More News on
Download The Economic Times News App to get Daily Market Updates & Live Business News.
Top Trending Stocks: Sensex Today Live, SBI Share Price, Axis Bank Share Price, HDFC Bank Share Price, Infosys Share Price, Wipro Share Price, NTPC Share Price
Get Unlimited Access to The Economic Times 
